Idiopathic Intracranial Hypertension

Mayo Clinic Proceedings

Volumn 69, Issue 2, 1994, Pages 169-180

  RADHAKRISHNAN, KURUPATH ^a   AHLSKOG, J ERIC ^a   GARRITY, JAMES A ^a   KURLAND, LEONARD T ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

cerebrospinal fluid; computed tomography; CSF; CT; idiopathic intracranial hypertension; IIH; magnetic resonance imaging; MRI

Indexed keywords

ACETAZOLAMIDE; ANTIBIOTIC AGENT; CHLORTALIDONE; CORTICOSTEROID; DEXAMETHASONE; ETACRYNIC ACID; FUROSEMIDE; GLUCOSE; PREDNISONE; PROTEIN;

BRAIN BLOOD VOLUME; BRAIN EDEMA; BRAIN PSEUDOTUMOR; CEREBROSPINAL FLUID EXAMINATION; DIFFERENTIAL DIAGNOSIS; EMPTY SELLA SYNDROME; ENDOCRINE DISEASE; EVOKED VISUAL RESPONSE; HUMAN; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; INTRAVENOUS DRUG ADMINISTRATION; LUMBAR PUNCTURE; NERVE DECOMPRESSION; NEUROLOGIC EXAMINATION; OBESITY; ORAL DRUG ADMINISTRATION; PAPILLEDEMA; PERIMETRY; POSTOPERATIVE COMPLICATION; REVIEW; SHUNTING; THROMBOSIS; VISUAL IMPAIRMENT; WEIGHT REDUCTION;

EID: 0027957187     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-6196(12)61045-3     Document Type: Review

References (100)

1. Ueber Meningitis serosa und verwandte Zustände
2. Papilledema and idiopathic intracranial hypertension: report of a familial occurrence
3. The rational management of idiopathic intracranial hypertension
4. Idiopathic intracranial hypertension: a prospective study of 50 patients
5. Pseudotumor cerebri
6. Whence pseudotumor cerebri? [editorial]
7. Benign forms of intracranial hypertension—“toxic” and “otitic” hydrocephalus
8. Benign intracranial hypertension
9. Visual loss in pseudotumor cerebri: follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss
10. Clinical course and prognosis of pseudotumor cerebri: a prospective study of 24 patients
11. Pseudotumor cerebri: incidence and pattern in North-Eastern Libya
12. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana
13. Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology in Rochester, Minn, 1976 to 1990
14. “Benign” intracranial hypertension: a survey of the clinical and radiological features, and long-term prognosis
15. Benign intracranial hypertension. I. Diagnosis and prognosis
16. Pseudotumor cerebri: clinical profile and visual outcome in 63 patients
17. Long-term intracranial pressure recording in the management of pseudotumor cerebri
18. Malignant pseudotumor cerebri: report of two cases
19. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study
20. Benign intracranial hypertension—its unusual manifestations
21. Unilateral and highly asymmetric papilledema in pseudotumor cerebri
22. Problems in the diagnosis and treatment of pseudotumor cerebri
23. Chronic papilledema simulating hyaline bodies of the optic disc: a case report
24. Transient visual obscurations with elevated optic discs
25. Drusen of the optic disk: a clinical and genetic study
26. Optic nerve head drusen and pseudotumor cerebri
27. Idiopathic intracranial hypertension without papilledema
28. Computed tomography in benign intracranial hypertension
29. Computed tomography ventricular size has no predictive value in diagnosing pseudotumor cerebri
30. Pseudotumor cerebri in men
31. Pseudotumor cerebri: CT findings and correlation with vision loss
32. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri
33. Cerebrospinal fluid physiology and the management of increased intracranial pressure
34. Pathogenesis of pseudotumor cerebri syndromes
35. Low CSF protein concentration in idiopathic pseudotumor cerebri
36. Cerebrospinal fluid protein and opening pressure in idiopathic intracranial hypertension (pseudotumor cerebri)
37. Cerebral venous sinus thrombosis presenting as idiopathic intracranial hypertension
38. Cerebral venous thrombosis in Behcet's disease: clinical study and long-term follow-up of 25 cases
39. The pseudotumor syndrome: disorders of cerebrospinal fluid circulation causing intracranial hypertension without ventriculomegaly
40. Brain edema and disorders of intracranial pressure
41. The search for causes of idiopathic intracranial hypertension: a preliminary case-control study
42. Development of pseudotumor cerebri after the removal of an adrenocorticotropic hormone-secreting pituitary adenoma: case report
43. Cushing's disease in childhood: benign intracranial hypertension after trans-sphenoidal adenomectomy
44. Benign intracranial hypertension and Cushing's disease
45. Pseudotumor cerebri, empty sella syndrome, and adrenal adenoma
46. Hypoparathyroidism and pseudotumor cerebri: an infrequent clinical association
47. Pseudotumor cerebri and hypothyroidism
48. Drug-related headache
49. Treatment of visual loss in pseudotumor cerebri associated with uremia
50. The diversity of neurologic events in systemic lupus erythematosus: prospective clinical and computed tomographic classification of 82 events in 71 patients
51. The pathophysiology of pseudotumor cerebri: an unsolved puzzle [editorial]
52. Intracranial pressure, conductance to cerebrospinal fluid outflow, and cerebral blood flow in patients with benign intracranial hypertension (pseudotumor cerebri)
53. Radioisotopic cisternography in benign intracranial hypertension of young obese women: a seven-case study and pathogenetic suggestions
54. Vacuolar transcellular channels as a drainage pathway for cerebrospinal fluid
55. CSF hydrodynamics in idiopathic intracranial hypertension: a long-term study
56. Brain swelling of unknown cause
57. Brain water accumulation in pseudotumour cerebri demonstrated by MR-imaging of brain water self-diffusion
58. Increased cerebral blood volume in benign intracranial hypertension
59. Cerebral hemodynamics and metabolism in pseudotumor cerebri
60. Effects of increased intracranial pressure on cerebral blood volume, blood flow, and oxygen utilization in monkeys
61. Pseudotumor cerebri: report of a familial occurrence
62. Pseudo-tumor cerebri: further studies
63. Familial pseudotumor cerebri and the empty sella syndrome
64. Familial intracranial hypertension: report of a case and review of the literature
65. Familial benign intracranial hypertension
66. Familial benign intracranial hypertension
67. Familial pseudotumor cerebri in male heterozygous twins
68. A familial coincidence of pseudotumor cerebri and communicating hydrocephalus
69. The subarachnoid spaces in children: normal variations in size
70. ‘Slit-ventricle syndrome’: etiology and treatment
71. Antimigraine treatment for slit ventricle syndrome
72. Optic disc edema in raised intracranial pressure. IV. Axoplasmic transport in experimental papilledema
73. Macular abnormalities in papilledema from pseudotumor cerebri
74. Pseudotumor cerebri and pregnancy
75. Factors affecting visual loss in benign intracranial hypertension
76. Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study
77. Contrast sensitivity testing in pseudotumor cerebri
78. Electrophysiology versus psychophysics in the detection of visual loss in pseudotumor cerebri
79. Visual loss in pseudotumor cerebri: incidence and defects related to visual field strategy
80. Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri)
81. Visual evoked potentials in pseudotumor cerebri
82. Visual loss in pseudotumor cerebri of childhood: a follow-up study
83. Permanent visual impairment in childhood pseudotumor cerebri
84. Does pseudotumor cerebri cause the empty sella syndrome?
85. Case report: hyperprolactinemia in a patient with pseudotumor cerebri
86. Absence of significant endocrine deficiencies in benign intracranial hypertension
87. Idiopathic intracranial hypertension
88. Pseudotumor cerebri treated by rice/reduction diet
89. Iatrogenic intraspinal epidermoid tumors
90. The production of cerebrospinal fluid in man and its modification by acetazolamide
91. Treatment of pseudotumor cerebri with Diamox (acetazolamide)
92. Reducing side effects of carbonic anhydrase inhibitors
93. How is pseudotumor cerebri diagnosed?
94. Benign intracranial hypertension: aspects of diagnosis and treatment
95. Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension
96. Optic nerve sheath decompression: the emerging indications
97. Modified optic nerve decompression in patients with functioning lumboperitoneal shunts and progressive visual loss
98. Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompression
99. Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompression [letter]
100. The efficacy of shunting procedures in pseudotumor cerebri [abstract]